Structure, Inhibitors, and Biological Function in Nervous System and Cancer of Ubiquitin-Specific Protease 46

被引:0
作者
Pham, Khanh Huyen Thi [1 ,2 ]
Tran, Manh Hung [1 ]
Nam, Le Ba [3 ]
Pham, Phu Tran Vinh [4 ]
Nguyen, Tan Khanh [5 ]
机构
[1] Univ Danang, Sch Med & Pharm, Dept Pharm, Danang, Vietnam
[2] Dongguk Univ, Coll Pharm, Seoul, South Korea
[3] Thanh Do Univ, Fac Pharm, Hanoi, Vietnam
[4] Univ Danang, VN UK Inst Res & Execut Educ, Dept Biomed Sci, Danang, Vietnam
[5] Dong A Univ, Sci Management Dept, Danang 550000, Vietnam
关键词
Ubiquitin-specific protease 46; deubiquitinating enzymes; cancer; inhibitor; nervous system; RENAL-CELL CARCINOMA; DEUBIQUITINATING ENZYME; HEPATOCELLUAR CARCINOMA; ANDROGEN RECEPTOR; NONCODING RNAS; USP46; DEGRADATION; STATISTICS; PATHWAY; ACTIVATION;
D O I
10.1177/11779322241285982
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Deubiquitinating enzymes (DUBs) prevent ubiquitination by eliminating ubiquitin from their substrates. Deubiquitinating enzymes have important roles in a number of cell biology subfields that are highly relevant to diseases like neurodegeneration, cancer, autoimmune disorders, and long-term inflammation. Deubiquitinating enzymes feature a well-defined active site and, for the most part, catalytic cysteine, which makes them appealing targets for small-molecule drug development. Ubiquitin-specific protease 46 (USP46) is a member of the ubiquitin-specific protease family, the largest subfamily of DUBs. Over the past 10 years, some studies have steadily demonstrated the significance of USP46 in several biological processes, although it was identified later and early research progress was modest. Specifically, in the last few years, the carcinogenic properties of USP46 have become more apparent. In the current review, we provide a comprehensive overview of the current knowledge about USP46 including its characteristics, structure, inhibitors, function in diseases, especially in the nervous system, and the correlation of USP46 with cancers.
引用
收藏
页数:11
相关论文
共 84 条
[1]   Regulation of AMPA receptor trafficking and synaptic plasticity [J].
Anggono, Victor ;
Huganir, Richard L. .
CURRENT OPINION IN NEUROBIOLOGY, 2012, 22 (03) :461-469
[2]   Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease [J].
Aron, Rebecca ;
Pellegrini, Pasquale ;
Green, Edward W. ;
Maddison, Daniel C. ;
Opoku-Nsiah, Kwadwo ;
Wong, Jinny S. ;
Daub, Aaron C. ;
Giorgini, Flaviano ;
Finkbeiner, Steven .
NATURE COMMUNICATIONS, 2018, 9
[3]  
Arora T., 2023, StatPearls
[4]   Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges [J].
Barua, David ;
Gupta, Ananya ;
Gupta, Sanjeev .
CANCER LETTERS, 2020, 486 :29-37
[5]   Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? [J].
Bellanger, Martine ;
Zeinomar, Nur ;
Tehranifar, Parisa ;
Terry, Mary Beth .
JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 :1-16
[6]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[7]   PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms [J].
Brognard, John ;
Sierecki, Emma ;
Gao, Tianyan ;
Newton, Alexandra C. .
MOLECULAR CELL, 2007, 25 (06) :917-931
[8]   Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C-elegans [J].
Burbea, M ;
Dreier, L ;
Dittman, JS ;
Grunwald, ME ;
Kaplan, JM .
NEURON, 2002, 35 (01) :107-120
[9]   Epidemiology of Renal Cell Carcinoma [J].
Capitanio, Umberto ;
Bensalah, Karim ;
Bex, Axel ;
Boorjian, Stephen A. ;
Bray, Freddie ;
Coleman, Jonathan ;
Gore, John L. ;
Sun, Maxine ;
Wood, Christopher ;
Russo, Paul .
EUROPEAN UROLOGY, 2019, 75 (01) :74-84
[10]   Renal cancer [J].
Capitanio, Umberto ;
Montorsi, Francesco .
LANCET, 2016, 387 (10021) :894-906